CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Option exercise Director acquired 4,507 shares (option exercise)
- 4 Option exercise Director acquired 4,507 shares (option exercise)
- 4 Option exercise Director acquired 4,507 shares (option exercise)
- 8-K Event Shareholder vote results
- 8-K Event Material agreement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 8-K Event Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Open-market buy Pres and CEO bought 6,300 shares at $7.86 ($49,532)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Pres and CEO bought 6,500 shares at $7.74 ($50,278)
- 8-K Event Other events
Page 13 of 44 · 872 filings